openPR Logo
Press release

Global Cancer Vaccine Market & Clinical Trial Insight 2025

12-20-2018 01:21 PM CET | Health & Medicine

Press release from: PNS Pharma

Global Cancer Vaccine Market & Clinical Trial Insight 2025

Recent published report “Global Cancer Vaccine Market & Clinical Trial Insight 2025“ by PNS Pharma highlights on going developments in the field of cancer vaccine market research and clinical trials. currently there are more than 15 cancer vaccines commercially available in the market and close to 370 are in clinical Trial or pipeline. Most of the vaccines in development phases are for the treatment of Breast cancer and Brain Cancer.

Download Report:

http://www.pnspharma.com/buy-report.php?reporttitle=Global-Cancer-Vaccine-Market-%26-Clinical-Trial-Insight-2025

“Global Cancer Vaccine Market & Clinical Trial Insight 2025” Report Highlight:

Global Cancer Vaccine market Opportunity: US$ 15 Billion opportunity
Personalized Cancer Vaccine: The Next growth Frontier
Global Cancer Vaccine Clinical insight by Indication & Phase of Development
Global Cancer Vaccine Pipeline: 369 Cancer Vaccines
Marketed Cancer Vaccines: 17 Cancer Vaccines
Maximum Vaccines in Pipeline for Brain & Breast Cancer: 43 Cancer Vaccines
Regulatory Landscape

Recent published report “Global Cancer Vaccine Market & Clinical Trial Insight 2025“ by PNS Pharma highlights on going developments in the field of cancer vaccine market research and clinical trials. currently there are more than 15 cancer vaccines commercially available in the market and close to 370 are in clinical Trial or pipeline. Most of the vaccines in development phases are for the treatment of Breast cancer and Brain Cancer.

Download Report:

http://www.pnspharma.com/buy-report.php?reporttitle=Global-Cancer-Vaccine-Market-%26-Clinical-Trial-Insight-2025

“Global Cancer Vaccine Market & Clinical Trial Insight 2025” Report Highlight:

Global Cancer Vaccine market Opportunity: US$ 15 Billion opportunity
Personalized Cancer Vaccine: The Next growth Frontier
Global Cancer Vaccine Clinical insight by Indication & Phase of Development
Global Cancer Vaccine Pipeline: 369 Cancer Vaccines
Marketed Cancer Vaccines: 17 Cancer Vaccines
Maximum Vaccines in Pipeline for Brain & Breast Cancer: 43 Cancer Vaccines
Regulatory Landscape

Rajesh Sharma
rajesh@pnspharma.com
PNS Pharma
New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cancer Vaccine Market & Clinical Trial Insight 2025 here

News-ID: 1453495 • Views: 154

More Releases from PNS Pharma

Global Gene Therapy Market To Witness Positive Outlook With More Than USD 8 Bill …
Gene therapy process has successfully gained popularity among the researchers all around the globe. Since its discovery, the primary driver of the market of the gene therapy process is considered to be its ability to alter the cause of the disease at the molecular level and that too precisely than the other available technologies. The technological advancements and the development in the gene delivery systems have developed a bright scope
Global Gene Therapy Market Size Sales To Surpass USD 8 Billion By 2026
" Global Gene Therapy Market Opportunity & Clinical Trials Insight 2026" Report Highlights: o Global Gene Therapy market Opportunity: > USD 8 Billion o Global Gene Therapy Pipeline:: > 1000 In Trials o Commercially Available Gene Therapies: 11 o US & Europe Are Key Markets Download Report: http://pnspharma.com/buy-report.php?reporttitle=Global-Gene-Therapy-Market-Opportunity-%26-Clinical-Trials-Insight-2026 1. Introduction to Gene Therapy 1.1 Gene Therapy: An Overview 1.2 History of Development 2. Gene Therapy & its Impact on Genetic Alterations 2.1 Gene Therapy as a Mastermind of Genetic Revolution
Global Breast Cancer Drug Market & Clinical Trial Insight 2025
" Global Breast Cancer Drug Market & Clinical Trial Insight 2025" Report Highlights: • Global Breast Cancer Drug Market: US$ 40 Billion Opportunity • Global Breast Cancer Drug Clinical Pipeline: More Than 550 Drugs • Marketed Breast Cancer Drugs: More Than 90 Drugs • Comprehensive Clinical Insight & Patent Information • Drug Trials, Pricing, Dosage, Cancer Prevalence Insight: 130 Graphs/Charts Download Report: http://pnspharma.com/buy-report.php?reporttitle=Global-Breast-Cancer-Drug-Market-%26-Clinical-Trial-Insight-2025 The applied science research has marked tremendous advancements in cutting off the epidemic cancer scenarios all around the
Global Peptide Drug Therapeutics Market Size Will Reach US$ 65 Billion by 2026
“Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026” report highlights: • Global Peptide Therapeutics Market Opportunity: US$ 65 Billion • Peptide Therapeutics Market Opportunity: US$ 22 Billion • Insight Peptide Drugs in Clinical Trials: 807 Peptides Drugs • Clinical & Patent Insight on 197 Marketed Peptides • Peptide Clinical Pipeline Is Dominated by Cyclic Peptides: 46 Peptides • Peptides Clinical Trials Insight by Phase, Indication & Company • Future Peptide Therapeutics Market Outlook Download Report: http://pnspharma.com/buy-report.php?reporttitle=Global-Peptide-Therapeutics-Market--%26-Clinical-Pipeline-Insight-2026 “Global Peptide Therapeutics Market

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and